(Q38006011)

English

Advances in treatment of lung cancer with targeted therapy

scientific article published on May 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

26 August 2017

Advances in treatment of lung cancer with targeted therapy (English)

1 reference

stated in

Europe PubMed Central

26 August 2017

1 reference

Philip T Cagle

1

1 reference

stated in

Europe PubMed Central

PubMed ID

22540298

retrieved

26 August 2017

Lucian R Chirieac

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

22540298

retrieved

26 August 2017

language of work or name

1 reference

1 May 2012

1 reference

stated in

Europe PubMed Central

26 August 2017

Archives of Pathology & Laboratory Medicine

1 reference

stated in

Europe PubMed Central

26 August 2017

136

1 reference

stated in

Europe PubMed Central

26 August 2017

504-509

1 reference

stated in

Europe PubMed Central

26 August 2017

5

1 reference

stated in

Europe PubMed Central

26 August 2017

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/1078-0432.CCR-08-0168

Identifiers

DOI

10.5858/ARPA.2011-0618-RA

1 reference

stated in

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

PubMed ID

22540298

retrieved

26 August 2017

(Q38006011)

Advances in treatment of lung cancer with targeted therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)